• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

部分肾切除术与根治性肾切除术治疗复杂肾肿块:多中心功能结局比较分析(Rosula 协作组)。

Partial versus radical nephrectomy for complex renal mass: multicenter comparative analysis of functional outcomes (Rosula collaborative group).

机构信息

Department of Urology, UC San Diego School of Medicine, La Jolla, CA, USA.

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy.

出版信息

Minerva Urol Nephrol. 2023 Aug;75(4):425-433. doi: 10.23736/S2724-6051.23.05123-6.

DOI:10.23736/S2724-6051.23.05123-6
PMID:37530659
Abstract

BACKGROUND

Utility of partial nephrectomy (PN) for complex renal mass (CRM) is controversial. We determined the impact of surgical modality on postoperative renal functional outcomes for CRM.

METHODS

We retrospectively analyzed a multicenter registry (ROSULA). CRM was defined as RENAL Score 10-12. The cohort was divided into PN and radical nephrectomy (RN) for analyses. Primary outcome was development of de-novo estimated glomerular filtration rate (eGFR)<45 mL/min/1.73 m. Secondary outcomes were de-novo eGFR<60 and ΔeGFR between diagnosis and last follow-up. Cox proportional hazards was used to elucidate predictors for de-novo eGFR<60 and <45. Linear regression was utilized to analyze ΔeGFR. Kaplan-Meier Analysis (KMA) was performed to analyze 5-year freedom from de-novo eGFR<60 and <45.

RESULTS

We analyzed 969 patients (RN=429/PN=540; median follow-up 24.0 months). RN patients had lower BMI (P<0.001) and larger tumor size (P<0.001). Overall postoperative complication rate was higher for PN (P<0.001), but there was no difference in major complications (Clavien III-IV; P=0.702). MVA demonstrated age (HR=1.05, P<0.001), tumor-size (HR=1.05, P=0.046), RN (HR=2.57, P<0.001), and BMI (HR=1.04, P=0.001) to be associated with risk for de-novo eGFR<60 mL/min/1.73 m. Age (HR=1.03, P<0.001), BMI (HR=1.06, P<0.001), baseline eGFR (HR=0.99, P=0.002), tumor size (HR=1.07, P=0.007) and RN (HR=2.39, P<0.001) were risk factors for de-novo eGFR<45 mL/min/1.73 m. RN (B=-10.89, P<0.001) was associated with greater ΔeGFR. KMA revealed worse 5-year freedom from de-novo eGFR<60 (71% vs. 33%, P<0.001) and de-novo eGFR<45 (79% vs. 65%, P<0.001) for RN.

CONCLUSIONS

PN provides functional benefit in selected patients with CRM without significant increase in major complications compared to RN, and should be considered when technically feasible.

摘要

背景

部分肾切除术 (PN) 治疗复杂肾肿瘤 (CRM) 的效用存在争议。我们旨在确定手术方式对 CRM 术后肾功能结果的影响。

方法

我们回顾性分析了一个多中心登记处 (ROSULA)。CRM 的定义为 RENAL 评分 10-12。该队列分为 PN 和根治性肾切除术 (RN) 进行分析。主要结局是新出现的估计肾小球滤过率 (eGFR)<45 mL/min/1.73 m。次要结局是新出现的 eGFR<60 和诊断与最后一次随访之间的 eGFR 变化。Cox 比例风险用于阐明新出现的 eGFR<60 和 <45 的预测因素。线性回归用于分析 eGFR 变化。Kaplan-Meier 分析 (KMA) 用于分析新出现的 eGFR<60 和 <45 的 5 年无复发率。

结果

我们分析了 969 名患者 (RN=429/PN=540;中位随访 24.0 个月)。RN 患者的 BMI 较低 (P<0.001),肿瘤较大 (P<0.001)。PN 的术后总体并发症发生率较高 (P<0.001),但主要并发症 (Clavien III-IV;P=0.702) 无差异。MVA 显示年龄 (HR=1.05,P<0.001)、肿瘤大小 (HR=1.05,P=0.046)、RN (HR=2.57,P<0.001) 和 BMI (HR=1.04,P=0.001) 与新出现的 eGFR<60 mL/min/1.73 m 的风险相关。年龄 (HR=1.03,P<0.001)、BMI (HR=1.06,P<0.001)、基线 eGFR (HR=0.99,P=0.002)、肿瘤大小 (HR=1.07,P=0.007) 和 RN (HR=2.39,P<0.001) 是新出现的 eGFR<45 mL/min/1.73 m 的危险因素。RN (B=-10.89,P<0.001) 与更大的 eGFR 变化相关。KMA 显示 RN 的新出现的 eGFR<60 (71% vs. 33%,P<0.001) 和 eGFR<45 (79% vs. 65%,P<0.001) 的 5 年无复发率较差。

结论

与 RN 相比,PN 为 CRM 患者提供了功能获益,且不会显著增加主要并发症,在技术可行时应考虑采用。

相似文献

1
Partial versus radical nephrectomy for complex renal mass: multicenter comparative analysis of functional outcomes (Rosula collaborative group).部分肾切除术与根治性肾切除术治疗复杂肾肿块:多中心功能结局比较分析(Rosula 协作组)。
Minerva Urol Nephrol. 2023 Aug;75(4):425-433. doi: 10.23736/S2724-6051.23.05123-6.
2
Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.机器人辅助部分肾切除术与微创根治性肾切除术治疗临床 T2a 期肾肿瘤:来自 ROSULA(机器人治疗大肾肿瘤)协作组的倾向评分匹配比较。
BJU Int. 2020 Jul;126(1):114-123. doi: 10.1111/bju.15064. Epub 2020 Jun 15.
3
Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.pT3a 病理分期上调的肾细胞癌行根治性和部分肾切除术的肿瘤学及功能结局:一项多机构分析
Clin Genitourin Cancer. 2020 Dec;18(6):e723-e729. doi: 10.1016/j.clgc.2020.05.002. Epub 2020 May 11.
4
Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.复杂肾肿物的部分或根治性肾切除术:ROSULA(大型肾肿物机器人手术)协作组的肿瘤学结局和并发症比较分析
World J Urol. 2023 Mar;41(3):747-755. doi: 10.1007/s00345-023-04279-1. Epub 2023 Mar 1.
5
Analysis of Renal Functional Outcomes After Radical or Partial Nephrectomy for Renal Masses ≥7 cm Using the RENAL Score.使用RENAL评分分析肾肿块≥7cm行根治性或部分肾切除术后的肾功能结果。
Urology. 2015 Aug;86(2):312-9. doi: 10.1016/j.urology.2015.02.067. Epub 2015 Jul 16.
6
Evaluation of functional outcome of bilateral kidney tumors after sequential surgery.双侧肾肿瘤序贯手术后功能结局的评估。
BMC Cancer. 2021 May 24;21(1):592. doi: 10.1186/s12885-021-08324-3.
7
Impact of renal surgery for cortical neoplasms on lipid metabolism.肾皮质肿瘤手术对脂代谢的影响。
BJU Int. 2014 Dec;114(6):837-43. doi: 10.1111/bju.12744. Epub 2014 Jul 15.
8
Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.部分和根治性肾切除术治疗良性肾肿瘤患者的 IV 期慢性肾脏病的总生存和发展。
Eur Urol. 2013 Oct;64(4):600-6. doi: 10.1016/j.eururo.2012.12.023. Epub 2012 Dec 25.
9
Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.老年T1-T2期肾肿瘤行部分肾切除术与根治性肾切除术的比较:并发症、肾功能及肿瘤学结局分析
Urology. 2017 Feb;100:151-157. doi: 10.1016/j.urology.2016.10.047. Epub 2016 Nov 23.
10
Predicting short- and long-term renal function following partial and radical nephrectomy.预测部分肾切除术和根治性肾切除术对短期和长期肾功能的影响。
Urol Oncol. 2023 Feb;41(2):110.e1-110.e6. doi: 10.1016/j.urolonc.2022.10.006. Epub 2022 Nov 10.

引用本文的文献

1
The predictive utility of the E-PASS score for postoperative complications in robot-assisted partial nephrectomy: a retrospective cohort study.E-PASS评分对机器人辅助部分肾切除术术后并发症的预测效用:一项回顾性队列研究。
BMC Urol. 2025 Aug 9;25(1):197. doi: 10.1186/s12894-025-01899-0.
2
Predicting hemorrhagic complications in robotic-assisted partial nephrectomy for renal tumors: simplifying risk assessment with tumor diameter and depth.预测机器人辅助肾肿瘤部分肾切除术的出血并发症:通过肿瘤直径和深度简化风险评估
J Robot Surg. 2025 Jul 10;19(1):368. doi: 10.1007/s11701-025-02537-5.
3
Evaluation of factors predicting adherent perinephric fat in laparoscopic retroperitoenal partial nephrectomy.
腹腔镜后腹膜肾部分切除术中预测肾周脂肪粘连相关因素的评估
BMC Urol. 2025 May 29;25(1):141. doi: 10.1186/s12894-025-01826-3.
4
Comparing different 3D virtual models generations for the planning of robotic partial nephrectomy: the added value of perfusion volumes implement.比较用于机器人辅助部分肾切除术规划的不同3D虚拟模型生成方法:灌注体积测量的附加价值。
World J Urol. 2025 Feb 17;43(1):126. doi: 10.1007/s00345-025-05504-9.
5
Comparison of robotic-assisted and laparoscopic partial nephrectomy based on the PADUA score and the predictive value of the PADUA score and the Mayo Adhesive Probability score for postoperative complications: a single-center retrospective study.基于PADUA评分比较机器人辅助与腹腔镜下部分肾切除术以及PADUA评分和梅奥粘连概率评分对术后并发症的预测价值:一项单中心回顾性研究。
J Cancer Res Clin Oncol. 2024 Dec 4;151(1):1. doi: 10.1007/s00432-024-06037-1.
6
Robot-Assisted Extravesical Ureteral Reimplantation (REVUR) in Pediatric Patients: A New Standard of Treatment for Patients with VUR-A Narrative Review.小儿患者的机器人辅助膀胱外输尿管再植术(REVUR):膀胱输尿管反流患者的一种新治疗标准——叙述性综述
Children (Basel). 2024 Sep 12;11(9):1117. doi: 10.3390/children11091117.
7
Seeking for the determinants of renal function loss after robot-assisted partial nephrectomy: what is below the tip of the iceberg.探寻机器人辅助部分肾切除术后肾功能丧失的决定因素:冰山一角之下是什么。
J Robot Surg. 2024 May 31;18(1):233. doi: 10.1007/s11701-024-01998-4.
8
Skill Transfer from Laparoscopic Partial Nephrectomy to the Hugo™ RAS System: A Novel Proficiency Score to Assess Surgical Quality during the Learning Curve.从腹腔镜部分肾切除术到Hugo™机器人辅助手术系统的技能转移:一种用于评估学习曲线期间手术质量的新型熟练度评分。
J Clin Med. 2024 Apr 11;13(8):2226. doi: 10.3390/jcm13082226.
9
Ablative Treatments for Small Renal Masses and Management of Recurrences: A Comprehensive Review.小肾肿瘤的消融治疗及复发管理:综述
Life (Basel). 2024 Mar 28;14(4):450. doi: 10.3390/life14040450.
10
Perioperative and Oncological Outcomes of Partial Versus Radical Nephrectomy for Complex Renal Tumors (RENAL Score ≥ 7): Systematic Review and Meta-Analysis.复杂肾肿瘤(RENAL 评分≥7)行部分肾切除术与根治性肾切除术的围手术期和肿瘤学结局:系统评价和荟萃分析。
Ann Surg Oncol. 2024 Jul;31(7):4762-4772. doi: 10.1245/s10434-024-15223-x. Epub 2024 Apr 17.